advanced search

EARLY INSIGHT

EARLY INSIGHT
DESIGNING A MORE VERSATILE AND MODERN WEARABLE DEVICE
Chaoyoung Lee and Mike Stout introduce the Horizon wearable micro-pump platform, a cutting-edge advancement in the drug delivery device market that marks a significant contribution to wearable drug-device design.
EARLY INSIGHT
TACKLING IRON-DEFICIENCY ANAEMIA: A LEAP FORWARD WITH A REVOLUTIONARY BUCCAL PATCH
Buddhadev P Chaudhuri and Frederik Ceyssens, discuss the challenges of iron-deficiency anaemia and introduce Keylika’s new buccal patch for iron delivery.
HOW DO YOU PERCEIVE INTRADERMAL DELIVERY? THINK AGAIN…
EARLY INSIGHT
Dr Nicky Bertollo
Pharma Latch
HOW DO YOU PERCEIVE INTRADERMAL DELIVERY? THINK AGAIN…
Nicky Bertollo, Adam Rock and Ronan Byrne discuss the benefits and limitations of intradermal delivery – and introduce the Pharma Latch Hollow intradermal injection device.
ACCURATE DELIVERY & PRECISE DOSING OF EYE DROPS: WHAT IF WE CHANGE THE INSTILLATION PROCEDURE?
EARLY INSIGHT
Dr Philippe Daull
Akrivision Technologies
ACCURATE DELIVERY & PRECISE DOSING OF EYE DROPS: WHAT IF WE CHANGE THE INSTILLATION PROCEDURE?
Philippe Daull and Pierre Roy discuss how changing the administration procedure for eye drops can improve the patient experience and eliminate health risks.
CAPA VALVE’S PATENTED TECHNOLOGY TRANSFORMS ANY SYRINGE INTO A DCD
EARLY INSIGHT
Dr Phil Green
Capa Valve
CAPA VALVE’S PATENTED TECHNOLOGY TRANSFORMS ANY SYRINGE INTO A DCD
Phil Green, Dale Charlton and Kevin Abbott introduce Capa Valve’s novel valve system for converting standard syringes into prefilled dual-chamber devices, capable of simplifying and improving the delivery of liquid-liquid and liquid-powder drug products, including reconstitution of lyophilised powders.
AN ECO-FRIENDLY AND ECONOMICAL APPROACH TO AUTOINJECTORS
EARLY INSIGHT
John Palmer-Felgate
Eco-inject
AN ECO-FRIENDLY AND ECONOMICAL APPROACH TO AUTOINJECTORS
John Palmer-Felgate introduces Eco-inject's patented innovation – a single-use, two-step autoinjector that is both eco-friendly and economical.
ACQUIRING A LIQUID BIOPSY INCIDENTAL TO INTRAVITREAL INJECTION
EARLY INSIGHT
Dr Alex Tumlinson
Twenty/Twenty Therapeutics
ACQUIRING A LIQUID BIOPSY INCIDENTAL TO INTRAVITREAL INJECTION
Alexandre Tumlinson introduces Twenty/Twenty Therapeutics' VitreoDx injection system to address emerging trends in intravitreal therapeutics.
SAY “NO MORE” TO NEEDLES: NEEDLE-FREE SELF-INJECTION TECHNOLOGY FOR PAINLESS, BETTER CARE
EARLY INSIGHT
Alina Su
NovaXS Biotech
SAY “NO MORE” TO NEEDLES: NEEDLE-FREE SELF-INJECTION TECHNOLOGY FOR PAINLESS, BETTER CARE
Alina Su discusses the need for improved and optimised remote healthcare to meet current challenges in the industry, and introduces Telosis, the company’s patent-pending connected needle-free injection device that is poised to provide answers to these challenges.
MISTGO<sup>®</sup> – A NEW MICRODOSING EYE MEDICATION DELIVERY SYSTEM
EARLY INSIGHT
Rie Saabye
EYE-GO
MISTGO® – A NEW MICRODOSING EYE MEDICATION DELIVERY SYSTEM
Rie Saabye and Morten Jacobsen discuss the benefits of a new microdosing eye medication delivery system for chronic ophthalmic diseases, such as dry eye disease and glaucoma.
CREATING A PLATFORM FOR NEBULISATION OF A WIDE RANGE OF DRUG TYPES AND FORMULATIONS
EARLY INSIGHT
Dr Elijah Nazarzadeh
Nebu~Flow
CREATING A PLATFORM FOR NEBULISATION OF A WIDE RANGE OF DRUG TYPES AND FORMULATIONS
Elijah Nazarzadeh and John Pritchard introduce Nebu~Flow – a novel class of nebuliser technology that represents a major step in the ability to deliver drugs efficiently to the lungs. overcoming the limitations of current systems and unlocking the potential of the inhalation route, including for systemic delivery.
CLIPhaler – INHALATION DEVICE DESIGN REDUCED TO THE MAXIMUM
EARLY INSIGHT
Dr Klaus-Dieter Beller
CLIPhaler – INHALATION DEVICE DESIGN REDUCED TO THE MAXIMUM
Klaus-Dieter Beller discusses the advantages of the inhalation route of administration, how his principle of design simplicity has informed the design of novel inhalation devices and introduces CLIPhaler, his latest and simplest device.
NO TYPE: AN APP TO PREDICT PATIENTS’ LIKELIHOOD TO TAKE MEDICATION AS PRESCRIBED
EARLY INSIGHT
Louisa Harvey
No Type
NO TYPE: AN APP TO PREDICT PATIENTS’ LIKELIHOOD TO TAKE MEDICATION AS PRESCRIBED
Louisa Harvey, Alper Hulusi, Bjarki Holm and Stefan Olafsson introduce their quick and accessible app for identifying whether or not a patient is likely to take their medication as prescribed.
PERSONALISED AEROSOL LOADING AND MANAGEMENT (PALM): A HANDHELD DEVICE FOR AEROSOL DRUG DELIVERY
EARLY INSIGHT
Dr Jason Brenker
Monash University
PERSONALISED AEROSOL LOADING AND MANAGEMENT (PALM): A HANDHELD DEVICE FOR AEROSOL DRUG DELIVERY
Jason Brenker, Tuncay Alan and Daniela Traini introduce the PALM – Personalised Aerosol Loading and Management – device, a unique, advanced drug delivery device enabling personalised delivery of aerosols to improve the efficacy of inhaled medications and patient compliance.
A NEW PLATFORM FOR SUPRACHOROIDAL DRUG DELIVERY USING STANDARD NEEDLES
EARLY INSIGHT
Timo Kangastupa
Visionisti
A NEW PLATFORM FOR SUPRACHOROIDAL DRUG DELIVERY USING STANDARD NEEDLES
Timo Kangastupa discusses the potential of the suprachoroidal space for highly effective, specifically targeted drug delivery to the choroid and retina, and how Visionisti’s technology simplifies and standardises the procedure, enabling the use of standard commercially available needles for suprachoroidal delivery.
PHARMACOKINETIC MODELS: INDISPENSABLE TOOLS FOR OPHTHALMIC DRUG DEVELOPMENT
EARLY INSIGHT
Dr Eva M del Amo
University of Eastern Finland DrugTech
PHARMACOKINETIC MODELS: INDISPENSABLE TOOLS FOR OPHTHALMIC DRUG DEVELOPMENT
Eva del Amo presents an overview of pharmacokinetic models for ophthalmic drugs, and discusses the value of these models for future drug development in the sector.
3D-PRINTED HOLLOW MICRONEEDLES: A NEW FRONTIER FOR TRANSDERMAL DRUG DELIVERY
EARLY INSIGHT
Dr Dimitrios Lamprou
Queen's University Belfast
3D-PRINTED HOLLOW MICRONEEDLES: A NEW FRONTIER FOR TRANSDERMAL DRUG DELIVERY
Dimitrios Lamprou and Essyrose Mathew discuss the potential of 3D-printed hollow microneedles for transdermal drug delivery.
USING BLOCKCHAIN AND DATA ANALYTICS FOR IMPROVED MEDICAL CANNABIS EFFICACY
EARLY INSIGHT
Brad Moore
Global Cannabis Applications Corp
USING BLOCKCHAIN AND DATA ANALYTICS FOR IMPROVED MEDICAL CANNABIS EFFICACY
Brad Moore and Tim Morch describe GCAC’s technology offering, a blockchain-based software system that is able to transparently track the progress of medical cannabis from cultivation through to consumption.
ENHANCED PROCESS CONTROL FOR LIPID-BASED NANOPARTICLES: LNPS AND LIPOSOMES
EARLY INSIGHT
Dr Antonio Costa
ENHANCED PROCESS CONTROL FOR LIPID-BASED NANOPARTICLES: LNPS AND LIPOSOMES
Antonio Costa discusses the use of lipid nanoparticles in the modern drug delivery industry and introduces the DIANT system for the continuous processing of nanoparticles with integrated process analytical technology, which can provide the quality required for these injectable, complex formulations.
SERITECH LEVERAGES FAST-DETACHING, DISSOLVING MICRONEEDLE FOR TRANSDERMAL DRUG DELIVERY
EARLY INSIGHT
Mr Richard Joye
SERITECH LEVERAGES FAST-DETACHING, DISSOLVING MICRONEEDLE FOR TRANSDERMAL DRUG DELIVERY
Richard Joye and Tim Morch discuss the advantages of using dissolvable microneedles for the delivery of vaccines, particularly in regards to storage and transport, and introduce SeriTech’s fast-detaching dissolvable microneedle technology.
GASTRIC FLOATING MICROCAPSULES FOR THE MANAGEMENT OF PARKINSON’S DISEASE
EARLY INSIGHT
Dr Sashi Kesavapany
GASTRIC FLOATING MICROCAPSULES FOR THE MANAGEMENT OF PARKINSON’S DISEASE
Kaarunya Sampathkumar, Joachim Loo and Sashi Kesavapany discuss current treatments for Parkinson’s disease and introduce an extended-releasing technology for polypharmacy oral formulations.
NEW ENGINE FOR PRIMARY CONTAINER INJECTORS: A POWERFUL MICRO LINEAR ACTUATOR
EARLY INSIGHT
Dr Brian Li
MicroMED Co Ltd
NEW ENGINE FOR PRIMARY CONTAINER INJECTORS: A POWERFUL MICRO LINEAR ACTUATOR
Brian Li, Jiunn-Ru Lai, Tsung-Chieh Cheng, Kuang-Hsiang Cheng, Min-Ru Wang, Chia-Chi Tina Feng, and Wen-Chi Huang introduce the company’s new engine for primary container injectors, the Primary Actuator, which targets the unmet needs in the autoinjector and wearable injector market as the market shifts towards large injection volumes.
AN ANGLED MICRONEEDLE PATCH FOR ENHANCED DRUG AND VACCINE DELIVERY
EARLY INSIGHT
Dr Nicky Bertollo
Pharma Latch
AN ANGLED MICRONEEDLE PATCH FOR ENHANCED DRUG AND VACCINE DELIVERY
Nicky Bertollo, Ronan Byrne and Andrew Muddle introduce Pharma Latch – a user-centric angled microneedle patch technology. They discuss its key benefits, such as dramatically increased payload potential, precision, low cost and variable patch-wear times, and highlight how Pharma Latch has the potential to overcome many of the limitations of existing routes of administration for therapeutics and vaccines.
MEDICSEN: NEEDLE-FREE SMARTPATCH FOR PAINLESS DRUG DELIVERY
EARLY INSIGHT
Dr Eduardo Jorgensen
MEDICSEN: NEEDLE-FREE SMARTPATCH FOR PAINLESS DRUG DELIVERY
Eduardo W Jørgensen, Juan César de Mercado and José Carlos Montesinos describe the Smartpatch, a novel technology for subcutaneous delivery of drugs via a comfortable, pain-free patch using sonophoresis, based on Medicsen’s patented miniaturised ultrasound technology.
EPIWATCH: A NOVEL LIFE-SAVING MICRO AUTOINJECTOR IN A SMART WATCH
EARLY INSIGHT
Amber Witteman
EPIWATCH: A NOVEL LIFE-SAVING MICRO AUTOINJECTOR IN A SMART WATCH
Amber Witteman, Thijs Roebers and Dirk-Jan Opstelten introduce the company’s patented innovation, a wearable autoinjector customised to fit the wrist.
INNOVATIVE DRUG-ELUTING ADHESIVES: APPLICATION IN CHRONIC RHINOSINUSITIS
EARLY INSIGHT
Dr Maria Pereira
INNOVATIVE DRUG-ELUTING ADHESIVES: APPLICATION IN CHRONIC RHINOSINUSITIS
Maria Pereira, Elise DeVries and Camille Legros introduce novel applications in the treatment of chronic rhinosinusitis for the company’s programmable synthetic polymers and an associated delivery device.
A FLEXIBLE, MODULAR PLATFORM TO DISRUPT THE BLOCKBUSTER MANUFACTURING MODEL
EARLY INSIGHT
Nick Rollings
A FLEXIBLE, MODULAR PLATFORM TO DISRUPT THE BLOCKBUSTER MANUFACTURING MODEL
Nick Rollings, Colin Barker and Richard Vellacott discuss the drug delivery scenario in the advanced therapy (AT) era, examining how the current slow-moving blockbuster treatment model is making way for a fast-moving, patient-focused era of personalised medicine
Top